Cargando…

Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy

Platinum-based chemotherapy remains a mainstay treatment for the management of advanced non-small cell lung cancer. A key cellular factor that contributes to sensitivity to platinums is the 5′-3′ structure-specific endonuclease excision repair cross-complementation group 1 (ERCC1)/ xeroderma pigment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feldmann, Daniel P., Heyza, Joshua, Zimmermann, Christoph M., Patrick, Steve M., Merkel, Olivia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221615/ https://www.ncbi.nlm.nih.gov/pubmed/32344513 http://dx.doi.org/10.3390/molecules25081994

Ejemplares similares

Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling
por: Arora, Sanjeevani, et al.
Publicado: (2018)

Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells
por: Arora, Sanjeevani, et al.
Publicado: (2016)

Hymenialdisine is Cytotoxic Against Cisplatin-Sensitive but Not Against Cisplatin-Resistant Cell Lines
por: Abdullah, Nada, et al.
Publicado: (2021)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
por: ZHAO, ZHIFANG, et al.
Publicado: (2014)

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2014)

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
por: Hu, Chen, et al.
Publicado: (2020)

Bag-1 Silence Sensitizes Non-Small Cell Lung Cancer Cells To Cisplatin Through Multiple Gene Pathways
por: Lv, Jiling, et al.
Publicado: (2019)

Histone deacetylase mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity
por: Ranganathan, Punithavathi, et al.
Publicado: (2016)

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells
por: LIU, WEN-XIN, et al.
Publicado: (2015)

Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin
por: Campagna, Roberto, et al.
Publicado: (2020)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells
por: Heyza, Joshua R., et al.
Publicado: (2018)

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis
por: ZHAO, XIAOZHEN, et al.
Publicado: (2015)

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Kiehl, Steffen, et al.
Publicado: (2017)

Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin
por: Xie, Si Ming, et al.
Publicado: (2008)

Silencing microRNA by interfering nanoparticles in mice
por: Su, Jie, et al.
Publicado: (2011)

In Vivo Targeting Replication Protein A for Cancer Therapy
por: VanderVere-Carozza, Pamela S., et al.
Publicado: (2022)

Silencing of Twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition
por: Jin, H-O, et al.
Publicado: (2012)

Silencing of TGIF sensitizes MDA-MB-231 human breast cancer cells to cisplatin-induced apoptosis
por: Pan, Teng, et al.
Publicado: (2018)

Promoting virus‐induced gene silencing of pepper genes by a heterologous viral silencing suppressor
por: Zhou, Yingjia, et al.
Publicado: (2021)

CRNDE silencing promotes apoptosis and enhances cisplatin sensitivity of colorectal carcinoma cells by inhibiting the Akt/mTORC1-mediated Warburg effect
por: Yang, Wenyu, et al.
Publicado: (2022)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

Enhancement of cisplatin sensitivity in lewis lung carcinoma by liposome-mediated delivery of a survivin mutant
por: Yu, Dan-Dan, et al.
Publicado: (2010)

Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin
por: Javanmardi, Sanaz, et al.
Publicado: (2020)

Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells
por: Mei, Ying, et al.
Publicado: (2017)

The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy
por: Liang, Lu, et al.
Publicado: (2022)

EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
por: Gorsic, Lidija K., et al.
Publicado: (2013)

Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score
por: Rubio, Karla, et al.
Publicado: (2023)

The Great Escape: How a Plant DNA Virus Hijacks an Imprinted Host Gene to Avoid Silencing
por: Benoit, Matthias
Publicado: (2020)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

Prophylactic consequences of sodium salicylate nanoparticles in cisplatin-mediated hepatotoxicity
por: Alkhalaf, Maha, et al.
Publicado: (2023)

Nanoparticle-Mediated Delivery of Satraplatin to Overcome Cisplatin Drug Resistance
por: Jiang, Xiaohan, et al.
Publicado: (2023)

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
por: Ganesh, Shanthi, et al.
Publicado: (2013)

Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
por: Xu, Xiaohui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5n6tjs6f6dr25u3692h1gseftf